NASDAQ:UNCY | Free Cash Flow | Unicycive Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.24M$8,000.00-$6.25M
2025-12-31-$8.03M$0.00-$8.03M
2025-03-31-$8.9M$16,000.00-$8.92M-1564.74%
2024-12-31-$6.55M$22,000.00-$6.57M
2024-03-31-$6.46M$6,000.00-$6.46M
2023-12-31-$4.44M$0.00-$4.44M
2023-03-31-$3.92M
2022-12-31-$6.08M$0.00-$6.08M
2022-03-31-$2.96M$2,000.00-$2.96M
2021-12-31-$1.4M
2021-03-31-$673,000.00
2020-12-31-$538,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$31.32M$24,000.00-$31.34M
2024-12-31-$28.58M$72,000.00-$28.65M
2023-12-31-$18.28M$12,000.00-$18.3M
2022-12-31-$15.65M$2,000.00-$15.65M
2021-12-31-$5.77M$29,000.00-$5.8M
2020-12-31-$1.46M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.